News | Artificial Intelligence | September 12, 2024

New eBook helps enhance your understanding of artificial intelligence in the realm of lung cancer diagnosis and screening.


Sept. 13, 2024 — Bayer Calantic Digital Solutions has announced the availability of a new eBook that addresses how artificial intelligence can help tackle the complexities of lung cancer screening and diagnosis.

"The Role of Artificial Intelligence in Lung Cancer Diagnosis and Screening" provides insight into the potential of AI to address some of the most burdensome lung cancer screening and diagnostic challenges.

This comprehensive eBook explores the potential role of AI in improving lung cancer screening strategies, identifying high-risk individuals, and enhancing diagnostic accuracy. Key topics include:

  • A look at various lung cancer screening strategies
  • A closer look at research addressing the difficulties and complexities involved in lung cancer screening
  • Exploring the potential impact of AI on identifying high-risk individuals, radiation dose reduction, image quality improvement, lung nodule detection, segmentation, and classification.
  • Discusses the hurdles to the adoption of AI in lung cancer screening and diagnosis and potential paths for future advancements.

Click here to download the free eBook.

 

 


Additional Content

News | Radiology Imaging

Nov. 1, 2026 — GE HealthCare recently introduced Allia Celeo,* a ceiling-mounted image guiding system, at the ...

Time November 05, 2026
arrow
News | Radiology Imaging

Nov. 2, 2026 — Neurophet and RapidAI have partnered to integrate Neurophet’s advanced neurodegenerative brain imaging ...

Time November 04, 2026
arrow
News | Ultrasound Imaging

Nov. 3, 2026 — GE HealthCare has announced two new AI-assisted capabilities for its Vscan Air handheld ultrasound system ...

Time November 03, 2026
arrow
News | Ultrasound Imaging

Oct. 28, 2026 — Clarius Mobile Health has announced 30 specialized AI models are now integrated into Clarius App 13.1 ...

Time November 02, 2026
arrow
News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
Subscribe Now